Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers

NCT02454699 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

DRUG: MBX400
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)